Genyro

Genyro is an early-stage biotechnology company focused on transforming biology into a programmable engineering material through next-generation DNA construction. The company's foundational technology, Sidewinder™, utilizes a breakthrough 'DNA page-number logic' based on DNA 3-way junctions to assemble long, complex, and highly repetitive genetic sequences with unprecedented precision and scale. By separating sequence information from assembly guidance, Genyro aims to overcome historical limitations in DNA writing to enable the rapid creation of synthetic genomes and complex biological systems. The platform is designed to accelerate innovation across diverse fields including medicine, materials science, and agriculture, with potential applications in gene therapy, vaccines, and AI-designed biomaterials. Led by industry veterans and academic pioneers from Caltech and Stanford, Genyro is positioning itself as a central infrastructure provider for the emerging bioeconomy.